Agios Pharmaceuticals | AGIO - Crediti Commerciali





Crediti Commerciali Cambiamento Data
AbbVie USD 12.77B 132M 2025-09
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Astellas Pharma JPY 810.23B 75.43B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bayer EUR 14.19B 720M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Exelixis USD 286.92M 24.38M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12